A Study of the Safety and Efficacy of Nebivolol in Hypertensive Patients

• Status: Completed
• Trial end date: 2003-03-01
• Target enrollment: 0
• Participant gender: All

Summary

A study to determine the safety, efficacy and superiority of nebivolol to placebo for the treatment of elevated blood pressure in patients with mild to moderate hypertension.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mylan Bertek Pharmaceuticals
• Treatments: Nebivolol

Criteria

Inclusion Criteria:

• An average sitting diastolic blood pressure of greater then or equal to 95 mmHg and less then or equal to 109 mmHg at baseline

Exclusion Criteria:

• Recent myocardial infarction or stroke

• Secondary hypertension

• Contraindications to beta-blocker therapy or discontinuation of prior antihypertensive agents

• Pregnancy, nursing or women of childbearing age not using appropriate contraception